Henan Taloph Pharmaceutical Stock Co Ltd (600222) — Cash Flow-to-Debt Ratio
Henan Taloph Pharmaceutical Stock Co Ltd (600222) has a Cash Flow-to-Debt Ratio of 0.01x as of September 2025, meaning its operating cash flow of CN¥22.69 Million could theoretically repay 0% of its total liabilities (CN¥2.09 Billion) in one year. See Henan Taloph Pharmaceutical Stock Co Ltd (600222) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Henan Taloph Pharmaceutical Stock Co Ltd Cash Flow-to-Debt Ratio (1998–2025)
Historical debt coverage capacity for Henan Taloph Pharmaceutical Stock Co Ltd across 28 annual periods. Also explore Henan Taloph Pharmaceutical Stock Co Ltd net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Henan Taloph Pharmaceutical Stock Co Ltd (1998–2025)
Year-by-year debt coverage analysis for Henan Taloph Pharmaceutical Stock Co Ltd. For market capitalisation and broader financial context, see Henan Taloph Pharmaceutical Stock Co Ltd market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.02x | CN¥47.16 Million | CN¥1.98 Billion | ▲ +212.2% |
| 2024 | -0.02x | CN¥-39.59 Million | CN¥1.86 Billion | ▼ -194.9% |
| 2023 | 0.02x | CN¥43.74 Million | CN¥1.95 Billion | ▲ +135.7% |
| 2022 | -0.06x | CN¥-124.41 Million | CN¥1.99 Billion | ▼ -226.1% |
| 2021 | 0.05x | CN¥99.66 Million | CN¥2.01 Billion | ▲ +25.8% |
| 2020 | 0.04x | CN¥73.43 Million | CN¥1.86 Billion | ▲ +35.8% |
| 2019 | 0.03x | CN¥41.53 Million | CN¥1.43 Billion | ▼ -64.8% |
| 2018 | 0.08x | CN¥119.47 Million | CN¥1.44 Billion | ▲ +364.2% |
| 2017 | 0.02x | CN¥23.17 Million | CN¥1.30 Billion | ▼ -70.9% |
| 2016 | 0.06x | CN¥70.60 Million | CN¥1.15 Billion | ▲ +42.0% |
| 2015 | 0.04x | CN¥49.27 Million | CN¥1.14 Billion | ▼ -46.6% |
| 2014 | 0.08x | CN¥89.54 Million | CN¥1.11 Billion | ▲ +1149.2% |
| 2013 | -0.01x | CN¥-6.65 Million | CN¥861.22 Million | ▼ -108.1% |
| 2012 | 0.10x | CN¥87.45 Million | CN¥912.93 Million | ▲ +75588.3% |
| 2011 | 0.00x | CN¥105.20K | CN¥831.28 Million | ▲ +100.4% |
| 2010 | -0.03x | CN¥-20.00 Million | CN¥641.92 Million | ▼ -173.6% |
| 2009 | 0.04x | CN¥21.45 Million | CN¥506.12 Million | ▼ -10.9% |
| 2008 | 0.05x | CN¥18.13 Million | CN¥381.43 Million | ▼ -28.0% |
| 2007 | 0.07x | CN¥21.34 Million | CN¥323.29 Million | ▲ +1234.1% |
| 2006 | 0.00x | CN¥1.59 Million | CN¥322.24 Million | ▲ +398.9% |
| 2005 | 0.00x | CN¥276.30K | CN¥278.70 Million | ▼ -98.5% |
| 2004 | 0.06x | CN¥18.25 Million | CN¥283.44 Million | ▲ +362.1% |
| 2003 | 0.01x | CN¥3.74 Million | CN¥268.36 Million | ▼ -50.6% |
| 2002 | 0.03x | CN¥7.47 Million | CN¥264.70 Million | ▼ -89.4% |
| 2001 | 0.27x | CN¥55.03 Million | CN¥206.07 Million | ▲ +4855.7% |
| 2000 | 0.01x | CN¥875.36K | CN¥162.45 Million | ▼ -99.2% |
| 1999 | 0.66x | CN¥99.32 Million | CN¥151.10 Million | ▲ +286.3% |
| 1998 | 0.17x | CN¥28.04 Million | CN¥164.79 Million | — |